Roche pins Tarceva hope on Cancer Drugs Fund after NICE rejects appeal
29 June 2011
Francesca Bruce
Please Login to read the full article.
29 June 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- CHMP extensions for Roche's Tarceva, Novartis' Afinitor and Wyeth's Enbrel
- Eisai mulls NICE appeal after another no for Halaven
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
- "Step change" Yervoy from BMS not cost effective for NICE: may need biomarker test
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
